Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Skin Cancer Prevention

Irrational risk assessment by sunless tanning products?

    • Congress Reports
    • Dermatology and venereology
    • Prevention and health care
    • RX
    • Studies
  • 2 minute read

Sunless tanning products may contribute to riskier UV radiation exposure behaviors, according to a recent study from the Mannheim Public Health Institute.

This misperception may lead to riskier behavior by exposing individuals to prolonged exposure to tanning beds or the sun without sunscreen. The results of the present study emphasize the importance of target group-specific prevention and, in particular, the propagation of safe SBP use.

Predictor of riskier behavior?

A research group from the Mannheim Public Health Institute investigated whether SBP use is more common among users of tanning beds (misperception hypothesis) and whether SBP consumers have higher risk “awareness” regarding tanning bed use (healthy alternative hypothesis). A dataset was used from the second wave of the NCAM study (2016 National Cancer Aid Monitoring on Sunbed Use), which was based on a representative sample in Germany (n=3000; age 14-45; 48.6% female, 51.4% male). The interviews were conducted by telephone.  Differences between SBP users and non-users with respect to the above aspects were assessed using a chi-square test.

 

 

Risk “awareness” varies

During the last 12 months, 7.5% of the respondents used SBP (Fig. 1). Users of tanning beds showed a higher prevalence of SBP use than those who used tanning beds previously or never (16.1% vs. 9.6% vs. 5.8%; p<0.001; Fig. 2).

 

 

Although SBP users had a higher risk of skin cancer due to family history (e.g., family history of malignant melanoma: 12.2% vs. 7.1%; p=0.016), they were less aware of the risks of tanning bed use than non-users of SBPs (e.g., agreement with the item “Regular use of tanning beds causes skin cancer”: 75.7% vs. 84.2%; p=0.001).

Conclusion

The parallel use of SBP and tanning beds found in this representative study supports the misconception hypothesis. This can have serious health consequences because a “fake” complexion due to SBP can result in risky UV radiation exposure behaviors (concerning tanning beds and/or sunbathing). Neither the misconception hypothesis nor the healthy alternative hypothesis can be definitively confirmed or rejected based on the data of the present study. Further studies are needed to verify whether and how dangerous SBP use is.

Source: 46th ADF Annual Meeting, Munich (D), March 13-16, 2019.

 

Literature:

  1. Diehl K, et al.: Sunless tanning products: Healthy alternative or risky addition to tanning bed use? Mannheim Institue of Public Health, Social and Preventive Medicine, Medical Faculty Mannheim, Heidelberg University, Poster presentation (P084), 46th ADF Annual Meeting, Munich, 13-16 March 2019.
  2. Diehl K, et al: Profile of sunless tanning product users: results from a Nationwide Representative Survey. Photodermatology, Photoimmunology & Photomedicine 2019; 95 (1); 40-46.

 

DERMATOLOGIE PRAXIS 2019; 29(3): 30 (published 7.6.19, ahead of print).

Autoren
  • Mirjam Peter, M.Sc.
Publikation
  • DERMATOLOGIE PRAXIS
Related Topics
  • Prevention
  • Skin cancer
  • tanning products
  • UV
Previous Article
  • Phenotyping of severe influenza courses

Be critical of steroids

  • Congress Reports
  • General Internal Medicine
  • Infectiology
  • RX
View Post
Next Article
  • Cardiology

Anticoagulation in daily practice – where to be careful?

  • Cardiology
  • Education
  • General Internal Medicine
  • RX
View Post
You May Also Like
View Post
  • 11 min
  • Peristomal skin health

Focus on preventive care options

    • Cases
    • CME continuing education
    • Dermatology and venereology
    • Gastroenterology and Hepatology
    • Infectiology
    • Physical medicine and rehabilitation
    • Prevention and health care
    • RX
    • Surgery
View Post
  • 7 min
  • Disease-modifying therapies for ATTR-CM

TTR stabilizers, gene silencing and gene scissors: where do we stand?

    • Cardiology
    • Congress Reports
    • Genetics
    • RX
    • Studies
View Post
  • 8 min
  • Proteins in wound healing

Do special amino acids lead to success?

    • CME continuing education
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • RX
    • Studies
View Post
  • 4 min
  • HER2+ early breast cancer

DESTINY-Breast11 – neoadjuvant T-DXd without anthracyclines

    • Education
    • Gynecology
    • Oncology
    • RX
    • Studies
View Post
  • 3 min
  • Lavender aromatherapy

Take away the fear of the dentist

    • Dentistry
    • Education
    • Pharmaceutical medicine
    • Phytotherapy
    • Psychiatry and psychotherapy
    • RX
    • Studies
View Post
  • 4 min
  • Digital dermatology: innovative project examples

AI and eHealth tools in HS care

    • Dermatology and venereology
    • General Internal Medicine
    • Practice Management
    • Prevention and health care
    • RX
    • Studies
View Post
  • 5 min
  • Mantle cell lymphoma

Recurrence after BTK inhibition – prognostic factors and treatment options

    • Education
    • Hematology
    • Oncology
    • RX
View Post
  • 3 min
  • Dementia risk with type 2 diabetes

SGLT2 inhibitors with advantages vs. DPP4 inhibitors

    • Education
    • Endocrinology and Diabetology
    • Geriatrics
    • Neurology
    • Pharmacology and toxicology
    • Psychiatry and psychotherapy
    • RX
    • Studies
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Communication as the key to therapy adherence
  • 2
    Solutions to the malnutrition dilemma
  • 3
    Solutions to the malnutrition dilemma
  • 4
    Focus on preventive care options
  • 5
    Fertility preservation from gonads to genomes to genoids

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.